Viemed Healthcare (VMD) FCF Margin Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 943.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -2,196.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -20.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2,679.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -461.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 417.00 |
| 10 | Viemed Healthcare | 373.53 Mn | 365.70 Mn | 42.83 Mn | -782.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -782.00 |
| Dec 31, 2025 | -531.00 |
| Sep 30, 2025 | 1,341.00 |
| Jun 30, 2025 | 412.00 |
| Mar 31, 2025 | -2,315.00 |
| Dec 31, 2024 | -4,032.00 |
| Sep 30, 2024 | 3,201.00 |
| Jun 30, 2024 | 2,114.00 |
| Mar 31, 2024 | -1,876.00 |
| Dec 31, 2023 | 2,311.00 |
| Sep 30, 2023 | 3,557.00 |
| Jun 30, 2023 | -3,709.00 |
| Mar 31, 2023 | 2,988.00 |
| Dec 31, 2022 | -1,754.00 |
| Sep 30, 2022 | -197.00 |
| Jun 30, 2022 | -1,135.00 |
| Mar 31, 2022 | 1,826.00 |
| Dec 31, 2021 | 3,528.00 |
| Sep 30, 2021 | -3,178.00 |